Manufacturing

Manufacturing

R-Pharm’s production designed with account to all latest GMP requirements, which is unprecedented for Russia, especially for the production of aseptic injection drug formulations.

Новости

Эксперты «Р-Фарм» встретились со студентами РХТУ им. Д.И.Менделеева

Эксперты «Р-Фарм» встретились со студентами РХТУ им. Д.И.Менделеева

14 апреля эксперты «Р-Фарм» встретились с бакалаврами и магистрами РХТУ им. Д.И. Менделеева. Студенты факультета химико-фармацевтических технологий и биомедицинских препаратов смогли увидеть виртуальную презентацию Ярославского завода готовых лекарственных форм, узнали об особенностях производственных площадок группы компаний «Р-Фарм», а также прослушали лекцию о проведении клинических испытаний лекарственных средств.

April 19, 2017

The Finals of the Olympiad as Part of the National Technological Initiative Took Place in Sochi

The Finals of the Olympiad as Part of the National Technological Initiative Took Place in Sochi

The results of the Olympiad organized with the support of R-Pharm group as part of the National Technological Initiative (NTI) were summarized in educational center “Sirius” in Sochi on March 29th. The Olympiad was held among senior schoolchildren and it took place in three stages. Three hundred children with the highest scores were selected out of twelve thousand competitors from all over Russia.

April 4, 2017

The First Batch of Drugs with Special Protective Marking Released at R-Pharm Enterprise

news

On March 14th, the first batch of Gerpecin drug with DataMatrix marking code was released at AO “ORTAT”, a pharmaceutical enterprise of R-Pharm group. 2D code on each drug package was made in full compliance with the requirements approved by the Ministry of Healthcare of the Russian Federation on February 2nd, 2017 as part of the experiment for marking drugs with control (identification) symbols and monitoring for the circulation of specific type of medicinal drugs.

March 28, 2017

R-Pharm Becomes a Partner of National Technological Initiative at “Sirius” Center

R-Pharm Becomes a Partner of National Technological Initiative at “Sirius” Center

The finals of the All-Russian engineering team Olympiad as part of the National Technological Initiative (NTI) was launched at the venue of the educational center “Sirius” in Sochi on March 26th. R-Pharm group became the partner of the event and the staff members of the company developed tasks and conducted competitive tests on engineering biological systems.

March 27, 2017

R-Pharm Findings of Large Scale Studies on Treatment of Chronic Hepatitis C are among 10% of the Best Research Papers Selected at the Largest Conference of the Asian Pacific Association for The Study of the Liver (APASL 2017)

R-Pharm Findings of Large Scale Studies on Treatment of Chronic Hepatitis C are among 10% of the Best Research Papers Selected at the Largest Conference of the Asian Pacific Association for The Study of the Liver (APASL 2017)

The annual Conference of the Asian Pacific Association for the Study of the Liver (APASL) is one of the most high profile medical events that gathers outstanding scholars and famous experts from all over the world. The latest developments and scientifically based research findings in the field of hepatology applied in day-to-day clinical practice are covered at the conference.

March 27, 2017
News Archive →